Australia, July 15 -- PTC Therapeutics Inc., owns the trademark (2536551) for 'PTSEEK' till Dec. 5, 2034.
Status: protected:
Registered/protected
Classes: 42 [Biotechnology research; chemical engineering; providing information on scientific and research studies in the field of clinical medicine via a website; hosting a web site featuring information on chemical engineering; research and development in the pharmaceutical and biotechnology fields; providing information on the subject of scientific research in the field of biochemistry and biotechnology; research and development of mrna drugs.] and 42 [Biotechnology research; Chemical engineering; Providing a web site featuring technology enabling others to access information in clinical medicine; Providing a web site featuring information on chemical engineering; Research and development in the pharmaceutical and biotechnology fields; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Research and development of mRNA drugs]
Type of Mark: Word
Date of Acceptance: May 6
Registration Advertised: July 14
For further details contact ARNOLD & SIEDSMA.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2536551.
Disclaimer: Curated by HT Syndication.
